A clinical trial to find out Effectiveness of Dalbergia sissoo extract (Dalzbone capsules) in femur fracture healing.
Phase 3
- Conditions
- Health Condition 1: S723- Fracture of shaft of femur
- Registration Number
- CTRI/2019/02/017690
- Lead Sponsor
- Pharmanza Herbal Pvt Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Radiologically diagnosed traumatic diaphyseal fracture of femur bone indifferent of compound, comminuted, closed or open fracture with surgical intervention.
2. Willing to give informed consent.
3. 0-5 days from the incident of fracture.
Exclusion Criteria
1. Pathological fracture.
2. Fracture patients with uncontrolled HTN(Blood Pressure >=140 mmHg or an average Diastolic Blood Pressure >=90 mmHg among those with HTN) or diabetes (Blood Glucose Level > 200 and Fasting Blood Glucose Level > 125 among those with diabetes)
3. Fracture in smokers.
4. Pregnant and breast feeding women.
5. History of allergy to herbal medicines.
6. Patient with renal failure, liver failure and or cardiac failure.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method